Literature DB >> 22236307

Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery.

Matthew J Haney1, Poornima Suresh, Yuling Zhao, Georgette D Kanmogne, Irena Kadiu, Marina Sokolsky-Papkov, Natalia L Klyachko, R Lee Mosley, Alexander V Kabanov, Howard E Gendelman, Elena V Batrakova.   

Abstract

BACKGROUND: Macrophage-carried nanoformulated catalase ('nanozyme') attenuates neuroinflammation and protects nigrostriatal neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication. This is facilitated by effective enzyme transfer from blood-borne macrophages to adjacent endothelial cells and neurons leading to the decomposition of reactive oxygen species. MATERIALS &
METHODS: We examined the intra- and inter-cellular trafficking mechanisms of nanozymes by confocal microscopy. Improved neuronal survival mediated by nanozyme-loaded macrophages was demonstrated by fluorescence-activated cell sorting.
RESULTS: In macrophages, nanozymes were internalized mainly by clathrin-mediated endocytosis then trafficked to recycling endosomes. The enzyme is subsequently released in exosomes facilitated by bridging conduits. Nanozyme transfer from macrophages to adjacent cells by endocytosis-independent mechanisms diffusing broadly throughout the recipient cells. In contrast, macrophage-free nanozymes were localized in lysosomes following endocytic entry.
CONCLUSION: Facilitated transfer of nanozyme from cell to cell can improve neuroprotection against oxidative stress commonly seen during neurodegenerative disease processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236307      PMCID: PMC3384770          DOI: 10.2217/nnm.11.156

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  37 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

2.  Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.

Authors:  Yuling Zhao; Matthew J Haney; Natalia L Klyachko; Shu Li; Stephanie L Booth; Sheila M Higginbotham; Jocelyn Jones; Matthew C Zimmerman; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

3.  Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

Authors:  Huanyu Dou; Christopher J Destache; Justin R Morehead; R Lee Mosley; Michael D Boska; Jeffrey Kingsley; Santhi Gorantla; Larisa Poluektova; Jay A Nelson; Mahesh Chaubal; Jane Werling; James Kipp; Barrett E Rabinow; Howard E Gendelman
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

4.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

5.  Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery.

Authors:  Elena V Batrakova; Serguei V Vinogradov; Sandra M Robinson; Michael L Niehoff; William A Banks; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2005 Jul-Aug       Impact factor: 4.774

6.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

7.  Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma.

Authors:  Nina Almqvist; Anna Lönnqvist; Susanne Hultkrantz; Carola Rask; Esbjörn Telemo
Journal:  Immunology       Date:  2008-03-19       Impact factor: 7.397

8.  Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants.

Authors:  Rosa A González-Polo; Germán Soler; Andrea Rodríguezmartín; Jose M Morán; José M Fuentes
Journal:  Cell Biol Int       Date:  2004       Impact factor: 3.612

Review 9.  Focusing on clathrin-mediated endocytosis.

Authors:  Joshua Z Rappoport
Journal:  Biochem J       Date:  2008-06-15       Impact factor: 3.857

10.  Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides.

Authors:  S V Vinogradov; T K Bronich; A V Kabanov
Journal:  Bioconjug Chem       Date:  1998 Nov-Dec       Impact factor: 4.774

View more
  20 in total

Review 1.  Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Authors:  Elena V Batrakova; Myung Soo Kim
Journal:  J Control Release       Date:  2015-08-01       Impact factor: 9.776

2.  First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Authors:  Paula Saá; Oksana Yakovleva; Jorge de Castro; Irina Vasilyeva; Silvia H De Paoli; Jan Simak; Larisa Cervenakova
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

3.  Macrophages with cellular backpacks for targeted drug delivery to the brain.

Authors:  Natalia L Klyachko; Roberta Polak; Matthew J Haney; Yuling Zhao; Reginaldo J Gomes Neto; Michael C Hill; Alexander V Kabanov; Robert E Cohen; Michael F Rubner; Elena V Batrakova
Journal:  Biomaterials       Date:  2017-06-18       Impact factor: 12.479

4.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

5.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Authors:  Dongfen Yuan; Yuling Zhao; William A Banks; Kristin M Bullock; Matthew Haney; Elena Batrakova; Alexander V Kabanov
Journal:  Biomaterials       Date:  2017-07-10       Impact factor: 12.479

Review 6.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

7.  Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Authors:  Natalia L Klyachko; Matthew J Haney; Yuling Zhao; Devika S Manickam; Vivek Mahajan; Poornima Suresh; Shawn D Hingtgen; R Lee Mosley; Howard E Gendelman; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2013-11-18       Impact factor: 5.307

Review 8.  Macrophages associated with tumors as potential targets and therapeutic intermediates.

Authors:  Serguei Vinogradov; Galya Warren; Xin Wei
Journal:  Nanomedicine (Lond)       Date:  2014-04       Impact factor: 5.307

9.  TPP1 Delivery to Lysosomes with Extracellular Vesicles and their Enhanced Brain Distribution in the Animal Model of Batten Disease.

Authors:  Matthew J Haney; Natalia L Klyachko; Emily B Harrison; Yuling Zhao; Alexander V Kabanov; Elena V Batrakova
Journal:  Adv Healthc Mater       Date:  2019-04-18       Impact factor: 9.933

10.  GDNF-expressing macrophages restore motor functions at a severe late-stage, and produce long-term neuroprotective effects at an early-stage of Parkinson's disease in transgenic Parkin Q311X(A) mice.

Authors:  Yuling Zhao; Matthew J Haney; Yeon S Jin; Olga Uvarov; Natasha Vinod; Yueh Z Lee; Benjamin Langworthy; Jason P Fine; Myosotys Rodriguez; Nazira El-Hage; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2019-10-31       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.